Old North State Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.8M | Sell |
7,158
-78
| -1% | -$16.8K | 0.93% | 28 |
|
|
2026
Q1 | $1.57M | Sell |
7,236
-33
| -0.5% | -$7.32K | 0.93% | 27 |
|
|
2025
Q4 | $1.66M | Sell |
7,269
-291
| -4% | -$66.3K | 0.98% | 26 |
|
|
2025
Q3 | $1.75M | Buy |
7,560
+76
| +1% | +$15.5K | 1.07% | 22 |
|
|
2025
Q2 | $1.39M | Sell |
7,484
-78
| -1% | -$14.5K | 0.95% | 24 |
|
|
2025
Q1 | $1.34M | Hold |
7,562
| – | – | 0.86% | 26 |
|
|
2024
Q4 | $1.34M | Buy |
7,562
+130
| +2% | +$23.9K | 0.86% | 26 |
|
|
2024
Q3 | $1.47M | Buy |
7,432
+95
| +1% | +$17.7K | 1.19% | 16 |
|
|
2024
Q2 | $1.26M | Buy |
7,337
+386
| +6% | +$63.9K | 1.09% | 19 |
|
|
2024
Q1 | $1.27M | Buy |
+6,951
| New | +$1.2M | 1.07% | 19 |
|
|
2023
Q3 | $1.23M | Sell |
8,269
-487
| -6% | -$71.5K | 0.96% | 23 |
|
|
2023
Q2 | $1.18M | Buy |
8,756
+522
| +6% | +$76.5K | 0.87% | 28 |
|
|
2023
Q1 | $1.31M | Buy |
8,234
+25
| +0.3% | +$3.82K | 0.91% | 22 |
|
|
2022
Q4 | $1.33M | Buy |
8,209
+243
| +3% | +$37.3K | 0.87% | 23 |
|
|
2022
Q3 | $1.07M | Buy |
7,966
+7,958
| +99,475% | +$1.14M | 0.92% | 25 |
|
|
2022
Q2 | $1.28K | Hold |
8
| – | – | 1.17% | 21 |
|
|
2022
Q1 | $1.32K | Sell |
8
-8,168
| -100% | -$1.19M | 1.06% | 25 |
|
|
2021
Q4 | $1.11M | Buy |
8,176
+1,659
| +25% | +$196K | 0.79% | 30 |
|
|
2021
Q3 | $703K | Sell |
6,517
-35
| -0.5% | -$4K | 0.63% | 35 |
|
|
2021
Q2 | $738K | Buy |
6,552
+137
| +2% | +$15.4K | 0.56% | 40 |
|
|
2021
Q1 | $694K | Buy |
6,415
+92
| +1% | +$9.84K | 0.55% | 41 |
|
|
2020
Q4 | $678K | Buy |
6,323
+249
| +4% | +$23.9K | 0.52% | 40 |
|
|
2020
Q3 | $532K | Sell |
6,074
-959
| -14% | -$90.3K | 0.36% | 48 |
|
|
2020
Q2 | $690K | Buy |
7,033
+110
| +2% | +$9.69K | 0.44% | 42 |
|
|
2020
Q1 | $528K | Sell |
6,923
-95
| -1% | -$8.09K | 0.38% | 50 |
|
|
2019
Q4 | $621K | Sell |
7,018
-13
| -0.2% | -$1.08K | 0.33% | 54 |
|
|
2019
Q3 | $532K | Sell |
7,031
-1,447
| -17% | -$99.2K | 0.36% | 58 |
|
|
2019
Q2 | $617K | Sell |
8,478
-1,940
| -19% | -$152K | 0.45% | 51 |
|
|
2019
Q1 | $839K | Sell |
10,418
-832
| -7% | -$68.1K | 0.59% | 39 |
|
|
2018
Q4 | $1.04M | Buy |
11,250
+271
| +2% | +$23.8K | 1.06% | 24 |
|
|
2018
Q3 | $1.04M | Buy |
+10,979
| New | +$1.04M | 0.98% | 24 |
|
Other funds holding ABBV
Old North State Trust's ABBV Position: Q2 2026 in Review
Old North State Trust reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $16.8K and leaving 7,158 shares worth $1.8M. The position accounts for 0.93% of the portfolio, ranked #28.
Old North State Trust first reported a position in ABBV in Q3 2018 and has held it in 31 quarters since. 4,219 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Old North State Trust held 7,158 shares of AbbVie worth $1.8M as of Q2 2026.
- Old North State Trust sold 78 AbbVie shares in Q2 2026, an estimated $16.8K.
- AbbVie made up 0.93% of Old North State Trust's portfolio in Q2 2026, its #28 holding.
- Old North State Trust first reported a position in AbbVie in Q3 2018 and has held it in 31 quarters since.
- 4,219 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Old North State Trust's 13F filing for Q2 2026, filed 17 Aug 2026.